Literature DB >> 8256590

Congenital muscular dystrophy. A study on the variability of morphological changes and dystrophin distribution in muscle biopsies.

Q H Leyten1, H J ter Laak, F J Gabreëls, W O Renier, K Renkawek, R C Sengers.   

Abstract

Histomorphological and histochemical variability was studied in muscle specimens from 30 patients with congenital muscular dystrophy (CMD). We found involvement of the central nervous system in 8 patients (Fukuyama CMD, F-CMD), involvement of the brain and the eyes in 5 patients (muscle, eye and brain disease, MEB-D) and hypodense white matter on the CT scans of 2 patients with (sub)normal intelligence (occidental-type cerebromuscular dystrophy, O-CMD). No morphological hallmarks were found to differentiate these subgroups. Only fat cell infiltration was found to be increased with increasing age in 'pure' CMD (pure-CMD). The morphological data did not appear to be correlated with the clinical severity or type of dystrophy (pure-CMD, F-CMD, MEB-D and O-CMD). Immunohistochemistry with dystrophin, vimentin and desmin antibodies in 14 patients (6 pure-CMD, 5 F-CMD, 2 MEB-D and 1 O-CMD) showed a normal expression pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256590     DOI: 10.1007/bf00369452

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  Dystrophin and nebulin in the muscular dystrophies.

Authors:  K Patel; T Voit; M J Dunn; P N Strong; V Dubowitz
Journal:  J Neurol Sci       Date:  1988-11       Impact factor: 3.181

2.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

3.  Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy.

Authors:  L V Nicholson; M A Johnson; D Gardner-Medwin; S Bhattacharya; J B Harris
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

4.  Congenital muscular dystrophy: a clinico-pathological and follow-up study of 15 patients.

Authors:  M Donner; J Rapola; H Somer
Journal:  Neuropadiatrie       Date:  1975-08

5.  Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations.

Authors:  Y Fukuyama; M Osawa; H Suzuki
Journal:  Brain Dev       Date:  1981       Impact factor: 1.961

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Congenital muscular dystrophy: a clinicopathologic report of 24 cases.

Authors:  J B McMenamin; L E Becker; E G Murphy
Journal:  J Pediatr       Date:  1982-05       Impact factor: 4.406

8.  Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.

Authors:  K Matsumura; I Nonaka; K P Campbell
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

9.  Congenital muscular dystrophy.

Authors:  Q H Leyten; F J Gabreëls; W O Renier; H J Ter Laak; R C Sengers; R A Mullaart
Journal:  J Pediatr       Date:  1989-08       Impact factor: 4.406

10.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  1 in total

1.  Congenital muscular dystrophy and severe central nervous system atrophy in two siblings.

Authors:  Q H Leyten; P G Barth; F J Gabreëls; K Renkawek; W O Renier; A A Gabreëls-Festen; H J ter Laak; M G Smits
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.